Arthritis, Rheumatoid study: BMS-986528
Official title A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
ClinicalTrials.gov ID: NCT07412704
What this study is testing
What is BMS-986528?
This is an investigational medicine being studied to see if it can help treat rheumatoid arthritis.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study aims to check if the drug is safe and to see if it helps reduce the effects of the disease.
- Who it's for
- People with rheumatoid arthritis that has not responded well to other treatments.
- What's involved
- Participants will take the study drug and undergo tests to monitor how their body handles it and how their arthritis changes.
- Time commitment
- The source text does not specify the duration or number of visits.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- \- Adult participants with rheumatoid arthritis (RA) who meet definition of difficult-to-treat.
You likely can't join if
- Juvenile arthritis or onset of inflammatory arthritis before age 18.
- Seronegative RA participants in whom polymyalgia rheumatica has not been ruled out.
- Active fibromyalgia with pain symptoms or signs that would interfere with joint assessment.
- Other protocol-defined Inclusion/Exclusion criteria apply.
The study team makes the final eligibility decision.
Where it is enrolling
- Denver, Colorado, United States
- Berlin, Germany
- Herne, Germany
- Sendenhorst, Germany
- Rozzano, Milano, Italy
- Roma, Italy
- A Coruña, A Coruña [La Coruña], Spain
- Córdoba, Spain
- Bern, Switzerland
- Geneva, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Denver, Colorado, United States; Berlin, Germany; Herne, Germany; Sendenhorst, Germany; Rozzano, Milano, Italy; Roma, Italy and 4 more locations. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.